Liver Biology and Pathobiology

You have full text access to this OnlineOpen article

Epidermal growth factor—induced activation of the insulin-like growth factor I receptor in rat hepatocytes

  1. Hazem Hallak,
  2. Giesla Moehren,
  3. Jei Tang,
  4. Mohamad Kaou,
  5. Mouhamad Addas,
  6. Jan B. Hoek,
  7. Raphael Rubin M.D.*

Article first published online: 7 MAR 2007

DOI: 10.1002/hep.1840360628

Issue

Hepatology

Hepatology

Volume 36, Issue 6, pages 1509–1518, December 2002

Additional Information

How to Cite

Hallak, H., Moehren, G., Tang, J., Kaou, M., Addas, M., Hoek, J. B. and Rubin, R. (2002), Epidermal growth factor—induced activation of the insulin-like growth factor I receptor in rat hepatocytes. Hepatology, 36: 1509–1518. doi: 10.1002/hep.1840360628

Author Information

  1. Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Philadelphia, PA

*Department of Pathology, Anatomy and Cell Biology, 1020 Locust St., Room 226 Alumni Hall, Philadelphia, PA 19107. fax: 215–955–8703

Publication History

  1. Issue published online: 7 MAR 2007
  2. Article first published online: 7 MAR 2007
  3. Manuscript Accepted: 15 SEP 2002
  4. Manuscript Received: 20 JUN 2002

Funded by

  • National Institutes of Health. Grant Numbers: AA09976, AA07186, AA08714

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (1042K)

Reference

  • 1
    Rubin R, Baserga R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 1995; 73: 311–331.
  • 2
    LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995; 16: 143–163.
  • 3
    Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1997; 1332: F105–F126.
  • 4
    LeRoith D. Insulin-like growth factor I receptor signaling—overlapping or redundant pathways? Endocrinology 2000; 141: 1287–1288.
  • 5
    Brunet A, Datta SR, Greenberg ME. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001; 11: 297–305.
  • 6
    Galetic I, Andjelkovic M, Meier R, Brodbeck D, Park J, Hemmings BA. Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase—significance for diabetes and cancer. Pharmacol Ther 1999; 82: 409–425.
  • 7
    Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60–66.
  • 8
    Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 2001; 22: 53–74.
  • 9
    Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK. Insulinlike growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest 1988; 81: 976–981.
  • 10
    Santos A, Yusta B, Fernandez-Moreno MD, Blazquez E. Expression of insulin-like growth factor-I (IGF-I) receptor gene in rat brain and liver during development and in regenerating adult rat liver. Mol Cell Endocrinol 1994; 101: 85–93.
  • 11
    Barreca A, Voci A, Minuto F, de Marchis M, Cecchelli E, Fugassa E, Giordano G, et al. Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Mol Cell Endocrinol 1992; 84: 119–126.
  • 12
    Scharf JG, Ramadori G, Dombrowski F. Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after lownumber pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest 2000; 80: 1399–1411.
  • 13
    Grunnet N, Peng X, Tygstrup N. Growth factors and gene expression in cultured rat hepatocytes. J Hepatol 1999; 31: 117–122.
  • 14
    Hartmann H, Schmitz F, Christ B, Jungermann K, Creutzfeldt W. Metabolic actions of insulin-like growth factor-I in cultured hepatocytes from adult rats. Hepatology 1990; 12: 1139–1143.
    Direct Link:
  • 15
    Kimura M, Ogihara M. Effects of insulin-like growth factor I and II on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Eur J Pharmacol 1998; 354: 271–281.
  • 16
    Liu YY, Rajkumar K, Murphy LJ. Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice. J Hepatol 1999; 30: 674–680.
  • 17
    Parkes JL, Cardell RR, Grieninger G. Insulin-like growth factors (IGF I and IGF II) mimic the effect of insulin on plasma protein synthesis and glycogen deposition in cultured hepatocytes. Biochem Biophys Res Commun 1986; 134: 427–435.
  • 18
    Hoek JB, Thomas AP, Rubin R, Rubin E. Ethanol-indúced mobilization of calcium by activation of phosphoinositide-specific phospholipase C in intact hepatocytes. J Biol Chem 1987; 262: 682–691.
  • 19
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254.
  • 20
    Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782–1788.
  • 21
    Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM. Transactivation of the EGF receptor mediates IGF-I-stimulated sh phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 2000; 275: 22583–22589.
  • 22
    Peterson JE, Kulik G, Jelinek T, Reuter CW, Shannon JA, Weber MJ. Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites. Requirement for transformation by src. J Biol Chem 1996; 271: 31562–31571.
  • 23
    Peterson JE, Jelinek T, Kaleko M, Siddle K, Weber MJ. Cphosphorylation and activation of the IGF-I receptor in src- transformed cells. J Biol Chem 1994; 269: 27315–27321.
  • 24
    Burgaud JL, Baserga R. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Exp Cell Res 1996; 223: 412–419.
  • 25
    Blum G, Gazit A, Levitzki A. Substrate competitive inhibitors of IGF-I receptor kinase. Biochemistry 2000; 39: 15705–15712.
  • 26
    Treadway JL, Morrison BD, Soos MA, Siddle K, Olefsky J, Ullrich A, McClain DA, et al. Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci U S A 1991; 88: 214–218.
  • 27
    Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000; 183: 1–9.
    Direct Link:
  • 28
    Karas M, Danilenko M, Fishman D, LeRoith D, Levy J, Sharoni Y. Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells. J Biol Chem 1997; 272: 16514–16520.
  • 29
    Lord AP, Bastian SE, Read LC, Walton PE, Ballard FJ. Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. J Endocrinol 1994; 140: 475–482.
  • 30
    Heding A, Gill R, Ogawa Y, De Meyts P, Shymko RM. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J Biol Chem 1996; 271: 13948–13952.
  • 31
    Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and Fyn T-dependent T cell activation. J Biol Chem 1996; 271: 695–701.
  • 32
    Traxler P, Bold G, Frei J, Lang M, Lydon N, Mett H, Buchdunger E, et al. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem 1997; 40: 3601–3616.
  • 33
    Sasaki Y, Zhang XF, Nishiyama M, Avruch J, Wands JR. Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration. J Biol Chem 1993; 268: 3805–3808.
  • 34
    Fujioka T, Ui M. Involvement of insulin receptor substrates in epidermal growth factor induced activation of phosphatidylinositol 3-kinase in rat hepatocyte primary culture. Eur J Biochem 2001; 268: 25–34.
    Direct Link:
  • 35
    Schwartzberg PL. The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene 1998; 17: 1463–1468.
  • 36
    Stover DR, Furet P, Lydon NB. Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain. J Biol Chem 1996; 271: 12481–12487.
  • 37
    Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 1994; 14: 4588–4595.
  • 38
    Baserga R, Resnicoff M, Dews M. The IGF-I receptor and cancer. Endocrine 1997; 7: 99–102.
  • 39
    Rao GN, Delafontaine P, Runge MS. Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cells. J Biol Chem 1995; 270: 27871–27875.
  • 40
    Sun XJ, Pons S, Asano T, Myers MG Jr, Glasheen E, White MF. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J Biol Chem 1996; 271: 10583–10587.
  • 41
    Liu W, Liu Y, Lowe JW Jr. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells. Endocrinology 2001; 142: 1710–1719.
  • 42
    Scharf JG, Knittel T, Dombrowski F, Muller L, Saile B, Braulke T, Hartman H, et al. Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology 1998; 27: 1275–1284.
    Direct Link:
  • 43
    Gressner AM, Lahme B, Brenzel A. Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells. Hepatology 1995; 22: 1507–1518.
  • 44
    Seiler AE, Ross BN, Green JS, Rubin R. Differential effects of ethanol on insulin-like growth factor-I receptor signaling. Alcohol Clin Exp Res 2000; 24: 140–148.
    Direct Link:
  • 45
    Li YM, Schacher DH, Liu Q, Arkins S, Rebeiz N, McCusker RH Jr, Dantzer R, et al. Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology 1997; 138: 362–368.
  • 46
    Chin E, Zhou J, Dai J, Baxter RC, Bondy CA. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994; 134: 2498–2504.
  • 47
    Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJ, Hill DJ. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994; 79: 1871–1876.
Get PDF (1042K)